Dr Oz nominated to lead CMS despite big pharma ties [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
position will oversee Medicare and Medicaid services, as well as plans under the Affordable Care Act (ACA). Known for his show "Dr Oz" and his unsupported homoeopathy recommendations, he represents the latest in a series of controversial nominations by the President-elect. If approved by the Senate, Oz will work alongside Robert F Kennedy Jr (RFK) to “take on the illness industrial complex, and all the horrible chronic diseases left in its wake”, according to a statement by Trump. The statement lauded Oz's expertise, saying that “America is facing a healthcare crisis, and there may be no physician more qualified and capable than Dr Oz to Make America Healthy Again”. Oz is a trained cardiothoracic surgeon with a degree in biology magna cum laude from Harvard University and experience working at New York City's Presbyterian Hospital and Columbia University. However, critics are concerned that Oz's medical background has become tinted by is celebrity status and (more consequentia
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Health Canada Authorizes CARVYKTI® (ciltacabtagene autoleucel) for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy [Yahoo! Finance]Yahoo! Finance
- Ophthalmic Equipment Market Size to Hit USD 105.20 Billion by 2033 | Straits Research [Yahoo! Finance]Yahoo! Finance
- EcoVadis' Coupa Connector Empowers Procurement Teams to Embed Sustainability into Every Purchasing Decision [Yahoo! Finance]Yahoo! Finance
- Which Is A Better Pick: JNJ Stock Or AbbVie? [Forbes]Forbes
- Dr. Oz Held Millions In Healthcare Investments, Raising Potential Conflicts For Medicare And Medicaid [Forbes]Forbes
JNJ
Earnings
- 10/15/24 - Beat
JNJ
Sec Filings
- 11/13/24 - Form 13F-HR
- 11/6/24 - Form 25-NSE
- 10/31/24 - Form 4/A
- JNJ's page on the SEC website